Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

55.21
+0.46000.84%
Post-market: 55.620.4100+0.74%19:50 EDT
Volume:371.11K
Turnover:20.46M
Market Cap:1.58B
PE:141.56
High:56.35
Open:54.86
Low:54.20
Close:54.75
52wk High:66.37
52wk Low:14.27
Shares:28.58M
Float Shares:22.30M
Volume Ratio:0.63
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:33.88
PE(LYR):-322.88

Loading ...

Is Impavido Launch Altering The Investment Case For Eton Pharmaceuticals (ETON)?

Simply Wall St.
·
Oct 07

Eton Pharma Chief Business Officer David Krempa Sells 4,166 Common Shares for $229,405.56

Reuters
·
Oct 07

Eton Pharmaceuticals Down over 15%, on Pace for Largest Percent Decrease Since November 2023

Dow Jones
·
Oct 01

Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis

MT Newswires Live
·
Sep 28

Eton Pharmaceuticals - Holds Exclusive Commercialization Rights for Impavido in the U.S.

THOMSON REUTERS
·
Sep 28

Eton Pharmaceuticals Announces U.S. Commercial Availability of Impavido® (Miltefosine) Capsules

THOMSON REUTERS
·
Sep 28

Eton Pharma Director Paul V. Maier Reports Disposal of Common Shares Worth $2.94 Million

Reuters
·
Aug 29

Eton Pharmaceuticals Hosts One-on-One Investor Meetings at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

Eton Pharmaceuticals (ETON) Stock May Be Fully Valued Following Raised Guidance

Simply Wall St.
·
Aug 27

Eton Pharma Chief Business Officer David Krempa Reports Disposal of 25,000 Common Shares Valued at $1.63 Million

Reuters
·
Aug 25

Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore

Simply Wall St.
·
Aug 24

Eton Pharma President and CEO Sean Brynjelsen Sells USD 6.19 Million in Common Shares

Reuters
·
Aug 21

Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone

Benzinga Earnings
·
Aug 17

Eton Pharmaceuticals price target raised to $70 from $40 at B. Riley

TIPRANKS
·
Aug 16

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Eton Pharmaceuticals is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 15

Top Midday Gainers

MT Newswires Live
·
Aug 15

Scienture Q2 Revenue Surges on Rezenopy Launch

Reuters
·
Aug 14

B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating

MT Newswires Live
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14